CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −9,437 | $87.74 | $828K | 514,519 |
| 2023-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award · Stock Option (Right to buy Common Stock) | +49,430 | 49,430 | ||
| 2023-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +10,110 | 89,967 | ||
| 2023-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −3,971 | $87.74 | $348K | 85,996 |
| 2023-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +23,070 | 23,070 | ||
| 2023-03-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +8,000 | $67.81 | $542K | 495,856 |
| 2023-03-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −8,000 | $90.45 | $724K | 487,856 |
| 2023-03-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −8,000 | 149,130 | ||
| 2023-03-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +15,000 | $67.81 | $1.0M | 502,856 |
| 2023-03-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −15,000 | $92.28 | $1.4M | 487,856 |
| 2023-03-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −15,000 | 157,130 | ||
| 2023-02-28 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +12,660 | 40,406 | ||
| 2023-02-28 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +10,980 | 51,386 | ||
| 2023-02-28 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +1,250 | 52,636 | ||
| 2023-02-28 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +20,200 | 76,925 | ||
| 2023-02-28 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +10,100 | 87,025 | ||
| 2023-02-28 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +7,424 | 94,449 | ||
| 2023-02-28 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +20,760 | 61,848 | ||
| 2023-02-28 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +10,380 | 72,228 | ||
| 2023-02-28 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +7,629 | 79,857 |
Page 17 of 23 · 450 trades